Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

3D MEDICINES

5.210
+0.1502.96%
Volume:128.50K
Turnover:664.13K
Market Cap:1.34B
PE:-6.38
High:5.380
Open:5.380
Low:5.050
Close:5.060
52wk High:10.020
52wk Low:1.600
Shares:258.00M
HK Float Shares:258.00M
Volume Ratio:0.77
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.816
ROE:-25.33%
ROA:-5.25%
PB:1.71
PE(LYR):-6.38
PS:2.74

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
3D MEDICINES
Exchange:
SEHK
Establishment Date:
2014
Employees:
183
Office Location:
No. 3 and No. 5, Laiyang Road,Qingdao,Shandong Province,China
Website:
http://www.3d-medicines.com
Zip Code:
266000
Phone:
- -
Fax:
- -
Introduction:
3D Medicines Inc is a holding company mainly engaged in the research and development (R&D) and commercialization of biopharmaceuticals. The Company focuses on the discovery, development and commercialization of innovative drugs in the field of cancer chronic disease treatment, and also lays out the field of cancer pain management. The Company has built a complete set of internal R&D systems, and has covered the entire process from drug discovery, preclinical development, clinical trials, and registration. The Company's first marketed drug, Envafolimab, is a subcutaneously injected PD-L1 inhibitor for the treatment of pan-tumor types. The Company also has a number of innovative drug research and development pipelines. The Company primarily operates in the domestic Chinese market.

Directors

Name
Position
GONG Zhao Long
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
Li Jin
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
LIAN Da Peng
Independent Director,Member of the Nomination Committee,Audit Committee Chairman
LIU Xin Guang
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
ZHOU Feng
Director,Audit Committee Member
CHEN Ya Wen
Director,Member of the Nomination Committee
ZHU Jin Qiao
Director

Shareholders

Name
Position
GONG Zhao Long
CEO
ZHANG Jing
CFO
XIA Fang
Board Secretary,Corporate Secretary
LI Jing Yi
Corporate Secretary
DING Gan
Chief Business Officer
HE Yue
Other Senior Executives